The Latest Covid Research is the Final Nail in the Coffin for Deniers of 'Natural Immunity'

One of the greatest mysteries of the Covid pandemic has been solved.

It is one of the great mysteries of the pandemic: Why have mainstream journalists, public health officials, and America's elected leaders ignored "natural immunity" to Covid from prior infections?

The incessant agenda to get everyone 'vaccinated' — despite the now undeniable body of evidence the mRNA shots do nothing to stop the spread of the virus — has defied basic scientific reasoning. Even if the mRNA shots appear to lower mortality rates for those who are at risk, prior infections provide equal or even superior protection due to their spurring of antibodies. After all, this is what the mRNA shots are meant to accomplish in the first place.

Research in the past has established that natural immunity is a real thing and actually works. A famous, widely cited Israeli study that showed "natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization" was recently replicated in an independent study. Nonetheless, there has been a stubborn refusal by the part of the media to acknowledge natural immunity exists, and the overwhelming majority of Democrat voters do not believe that it works against Covid.

Enter a new study on natural immunity published in the European Journal of Immunology. The cutting-edge research shows that not only is natural immunity effective, it is superior to vaccinated immunity because it is much longer-lasting.

"Most subjects develop antibodies to SARS-CoV-2 following infection," the study states. "In order to estimate the duration of immunity induced by SARS-CoV-2 it is important to understand for how long antibodies persist after infection in humans... We found that NAb  [natural antibodies] against the WT virus [B-lineage variants] persisted in 89% and S-IgG in 97% of subjects for at least 13 months after infection."

Eat your heart out, Big Pharma. Nature's immunization system beats your leaky, ineffective products any day of the week. Let's dig a little deeper and examine the results:

The study's results show the overwhelming majority of subjects received natural immunity from prior infection, regardless of whether the case was 'severe' or 'mild.' The researchers also sought to assess if natural immunity to certain variants of concern can be expected to protect against future variants.

"Previous infection with SARS-CoV-2 has shown to induce effective immunity and protection against reinfections in most individuals," the study says. "In animal studies, a protective antibody titer against SARS-CoV-2 infection has been suggested to be low. Higher IgG antibody levels against SARS-CoV-2 among healthcare workers within three months after vaccination were found to be associated with lower infectivity. However, a protective threshold for humans is still under debate and subject to the standardization of serological methods. The accumulating research data on the persistence of antibodies after natural infection, and NAbs in particular, will provide important insight into estimating for how long antibodies induced by Coronavirus disease 2019 (COVID-19) vaccination can be expected to persist and provide protection against emerging SARS-CoV-2 variants."

It is important to note that the Centers for Disease Control and Prevention refuses to accept the presence of antibodies as a demonstration of natural immunity to Covid-19. The CDC insists on every eligible person getting vaccinated, regardless of prior infection.

• Antibody testing is not currently recommended to assess for immunity to SARS-CoV-2 following COVID-19 vaccination, to assess the need for vaccination in an unvaccinated person, or to determine the need to quarantine after a close contact with someone who has COVID-19. Some antibody tests will not detect the antibodies generated by COVID-19 vaccines. Because these vaccines induce antibodies to specific viral protein targets, post-vaccination antibody test results will be negative in persons without history of previous infection, if the test used does not detect antibodies induced by the vaccine.

• All eligible people should be vaccinated, including unvaccinated people who have previously been infected and have detectable antibodies.

• Unvaccinated persons, including those who have previously tested antibody positive, should follow current recommendations to prevent SARS-CoV-2 infection.

There is no credible scientific reasoning provided — only a vague appeal that it is hard to test for the specific antibodies provided by the "vaccines." Needless to say, this is not a valid argument.

Additionally, the CDC itself claims that there have been 146.6 million prior infections in the United States (as of October 2). Based on its calculation and the current reported 52 million "cases," this would put prior infections and natural immunity at around 200 million people.

The Mayo Clinic once considered 200 million Americans with vaccinated or natural immunity to be sufficient to claim "herd immunity." Obviously, the "experts" (who have been wrong in countless ways) continue to move the goalposts to further the total-vaccination/zero-Covid agenda at all costs.

The European Journal of Immunology nonetheless demonstrates that natural immunity from prior infection is both durable and longer-lasting than vaccinated immunity, although elderly patients may benefit less from this form of immunity.

"Previous studies have indicated that the presence of antibodiesto SARS-CoV-2 was associated with a significantly reduced risk of SARS-CoV-2 reinfection among healthcare workers for upto 7 months after infection," the study points out. "We observed that S-IgG antibodies [one of three types tested in the study] and NAbs [natural antibodies] persist at least a year after infection in most individuals. This strongly suggests that protection against reinfection is long-lived, although antibody-mediated immunity may not persist equally well among elderly subjects."

"The results of our study support previous findings indicating that protection against infection mediated by NAbs may be impaired against the VOCs [variants of concern], especially after a mild disease," the study's authors continue. "While in the absence of NAbs reinfection is possible, cellular immunity is not similarly affected by mutations in the RBD site [receptor-binding domain on the virus] and is likely to provide long-term protection against severe disease."

It should be noted that these aren't some rogue scientists who happened to get a journal article smuggled through peer-review: The nine authors include members of the Department of Health Security and Department of Public Health and Welfare in Helsinki, Finland.

As a sidenote, RBD mutation [D614G S trimer mutation] is one key characteristic of the Omicron variant. Furthermore, South Africa data suggest that prior infection to the Delta variant confers natural immunity to the Omicron variant.

But the final nail in the coffin for the media's natural immunity deniers is a recent study that was conducted on children.